05/27/2026
RADIN Health and AZmed announced an expansion of their strategic partnership following a new FDA clearance for the Rayvolve AI Suite’s AZtrauma module.
According to the companies, the expanded clearance broadens the module’s capabilities beyond fracture detection to include detection of joint effusions and dislocations on X-rays in adult and pediatric patients ages 2 and older.
The expanded FDA clearance for AZtrauma adds detection of joint effusions and dislocations and broadens the scope of its X-ray AI suite.